2020
Treatment of Bullous Pemphigoid in People Aged 80 Years and Older: A Systematic Review of the Literature
Oren-Shabtai M, Kremer N, Lapidoth M, Sharon E, Atzmony L, Nosrati A, Hodak E, Mimouni D, Levi A. Treatment of Bullous Pemphigoid in People Aged 80 Years and Older: A Systematic Review of the Literature. Drugs & Aging 2020, 38: 125-136. PMID: 33230804, DOI: 10.1007/s40266-020-00823-5.Peer-Reviewed Original ResearchConceptsOlder patientsBullous pemphigoidTopical corticosteroidsCohort studyTreatment of bullous pemphigoidSide effect profileRetrospective cohort studyNational Institutes of Health databaseProspective cohort studySystematic reviewBackgroundBullous pemphigoidRandomized controlled trialsSignificant adverse effectsPartial responseSystemic corticosteroidsCase seriesTherapeutic optionsPatient selectionTreatment modalitiesAdverse eventsOlder adultsConclusionsCurrent dataPrimary outcomeSecondary outcomesUS National Institutes
2009
Inherited and acquired predispositions for thrombosis in immunocompetent patients with cytomegalovirus-associated thrombosis
Atzmony L, Grosfeld A, Saar N, Justo D. Inherited and acquired predispositions for thrombosis in immunocompetent patients with cytomegalovirus-associated thrombosis. European Journal Of Internal Medicine 2009, 21: 2-5. PMID: 20122604, DOI: 10.1016/j.ejim.2009.10.002.Peer-Reviewed Original ResearchConceptsImmunocompetent adultsInherited predispositionImmunocompetent patientsFactor V Leiden mutationV Leiden mutationThrombosis risk factorsImmunocompromised patientsInherited thrombophiliaOral contraceptivesCase seriesCase reportElderly patientsClinical circumstancesThrombosisClinical importanceRisk factorsPatientsPredispositionComplicationsCMVAdultsReportsThrombophiliaContraceptionInfants